Table 2.
Control of people with type 2 diabetes receiving their first insulin therapy.
| n | Pre-therapy HbA1ca Mean % (SD) | Post-therapy HbA1cb, Mean % (SD) | Mean difference Pre-HbA1c – PostHbA1c (95% CI) | P-value | Number (%) with HbA1c ≥7.5% post-therapy | Number (%) with HbA1c ≥8.5% post-therapy | |
|---|---|---|---|---|---|---|---|
| All | 1513 | 9.85 (1.96) | 8.51 (1.58) | 8.51 (1.58) | <0.001 | 1110 (73.36%) | 703 (46.46) |
| Pre-2003 | 784 | 9.96 (1.98) | 8.55 (1.63) | 8.55 (1.63) | <0.001 | 581 (74.11) | 367 (46.81) |
| Post-2003 | 729 | 9.74 (1.92) | 8.48 (1.52) | 8.48 (1.52) | <0.001 | 529 (72.57) | 336 (46.09) |
a
Pre-therapy HbA1c (haemoglobin A1c) is the last available HbA1c assessment in the 6 months prior to initiation of insulin
b
Post-therapy HbA1c is the last available HbA1c assessment in the 6 months following initiation of insulin.